Avita Medical Ltd (NASDAQ:RCEL)

Delayed Data
As of Feb 25
 -0.18 / -1.93%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Avita Medical Ltd have a median target of 11.55, with a high estimate of 12.00 and a low estimate of 10.68. The median estimate represents a +26.04% increase from the last price of 9.16.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Hold stock in Avita Medical Ltd. This rating has held steady since February, when it was downgraded from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 20

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly --
Growthannually 47.87%


Growthquarterly 34.37%
Growthannually 50.63%
Key to the earnings and sales forecast charts.